- Home
- IPST vs TCRT Comparison
IPST vs TCRT Comparison
Compare IPST & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPST | TCRT |
|---|---|---|
| Founded | 2011 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 2.4M |
| IPO Year | 2024 | 2025 |
Fundamental Metrics
Financial Performance| Metric | IPST | TCRT |
|---|---|---|
| Price | $2.95 | $0.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 278.5K | ★ 382.8K |
| Earning Date | 11-17-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.66 |
| EPS | N/A | ★ N/A |
| Revenue | $8,402,488.00 | ★ $15,900,000.00 |
| Revenue This Year | $66.82 | N/A |
| Revenue Next Year | $60.33 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 5.41 | N/A |
| 52 Week Low | $0.24 | $0.95 |
| 52 Week High | $25.34 | $4.57 |
Technical Indicators
Market Signals| Indicator | IPST | TCRT |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 31.10 |
| Support Level | $2.30 | N/A |
| Resistance Level | $3.95 | $2.09 |
| Average True Range (ATR) | 0.50 | 0.17 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 27.07 | 8.18 |
Price Performance
Historical ComparisonAbout IPST Heritage Distilling Holding Company Inc.
IP Strategy Holdings Inc operate a diversified business centered on digital asset-based infrastructure and intellectual property (IP) management, supplemented by a legacy craft spirits operating segment. The Company provides public market investors with broad exposure to the around $80 trillion programmable intellectual property economy in a regulated equity format. Its treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.